Sucrose

Sucrose

SCHEMBL7861331

O=S(=O)([O-])[O-].OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.[Na+].[Na+]

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sucrose. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.70
CCNB1 P14635 1/20 0.70
CA2 P00918 7/20 0.48
CA9 Q16790 1/20 0.48
LDHA P00338 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 3/20 0.41
ADORA1 P30542 1/20 0.37
TYR P14679 1/20 0.37
PTPN1 P18031 1/20 0.37
CA1 P00915 6/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sucrose SCHEMBL2383084 0.97 CDK1 (0.70) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL6241474 0.97 CDK1 (0.70) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL3797239 0.97 CDK1 (0.70) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL5012470 0.97 CDK1 (0.70) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL5972240 0.97 CDK1 (0.70) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL1001768 0.97 CDK1 (0.70) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL6638490 0.96 CDK1 (0.68) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL9800251 0.96 CDK1 (0.68) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL8795457 0.94 CDK1 (0.68) CDK1CCNB1CA2CA9LDHA
Sucrose SCHEMBL3506279 0.94 CDK1 (0.68) CDK1CCNB1CA2CA9LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0549794-B1 PRODUCTION OF A STOCK SOLUTION OF SUCRALFATE SUSPENDED IN WATER CHUGAI SEIYAKU BR KABUSHIKI KA (JP) 2001-11-28 EP claimed
US-5563258-A ANTIULCER AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1996-10-08 US claimed
EP-0549794-A1 STOCK SOLUTION OF SUCRALFATE SUSPENDED IN WATER AND PRODUCTION THEREOF Chugai Seiyaku Kabushiki Kaisha (JP) 1993-07-07 EP claimed
CN-114099437-A Stable camptothecin pharmaceutical compositions 易普森生物制药有限公司 2022-03-01 CN disclosed
CN-114073678-A Stable camptothecin pharmaceutical compositions 易普森生物制药有限公司 2022-02-22 CN disclosed
CN-108366965-B Stable camptothecin pharmaceutical compositions 易普森生物制药有限公司 2021-10-01 CN disclosed
CN-1192780-C Therapeutical agent TAKARA SHUZO CO (JP) 2005-03-16 CN disclosed
CN-1355703-A Therapeutical agent TAKARA SHUZO CO (JP) 2002-06-26 CN disclosed
EP-0549794-B1 PRODUCTION OF A STOCK SOLUTION OF SUCRALFATE SUSPENDED IN WATER CHUGAI SEIYAKU BR KABUSHIKI KA (JP) 2001-11-28 EP disclosed
US-5767104-A TOPICALLY ADMINISTERING AN EFFECTIVE AMOUNT OF A SULFATED SACCHARIDE, SALT OR COMPLEX BM RESEARCH A/S (DK) 1998-06-16 US disclosed
US-5618798-A ADMINISTERING SUCROSE OCTASULFATE BM RESEARCH A/S (DK) 1997-04-08 US disclosed
US-5563258-A ANTIULCER AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1996-10-08 US disclosed
EP-0469010-B1 COSMETIC COMPOSITION BM RES AS (DK) 1996-02-28 EP disclosed
WO-1994000476-A1 USE OF WATER-SOLUBLE SUCROSES FOR THE TREATMENT AND/OR PREVENTION OF LESION OR INFLAMMATION IN THE DIGESTIVE TRACT BUKH MEDITEC A/S (DK) 1994-01-06 WO disclosed
EP-0549794-A1 STOCK SOLUTION OF SUCRALFATE SUSPENDED IN WATER AND PRODUCTION THEREOF Chugai Seiyaku Kabushiki Kaisha (JP) 1993-07-07 EP disclosed
CN-1060599-A COSMETIC COMPOSITION BUKH MEDITEC (DK) 1992-04-29 CN disclosed
EP-0469010-A1 COSMETIC COMPOSITION. BUKH MEDITEC (DK) 1992-02-05 EP disclosed
WO-1990012561-A1 COSMETIC COMPOSITION BUKH MEDITEC A/S (NIELS BUKH A/S) (DK) 1990-11-01 WO disclosed